Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane - PubMed
Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane
J Denis et al. Gut. 1978 Sep.
Abstract
Forty-one patients with fulminant hepatic failure and coma underwent 180 periods of haemodialysis with polyacrylonitrile membrane (AN 69 HD). Hepatic failure was due to viral hepatitis in 40 and drugs in one. Total recovery of consciousness occurred in 17 patients (43.6%), and partial in seven (17.9%)--that is, an overall figure of 61.5%. Regain of consciousness was not related to liver regeneration as assessed by levels of factor V and hepatocyte volume fraction. At the time of the first haemodialysis, neurological status was significantly impaired in the patients who could not be aroused. Mean duration of coma grade IV averaged 6.1 +/- 4.3 days and mean duration of illness until death or decerebration 8.6 +/- 8.3 days. Of the 17 patients who totally regained consciousness, nine recovered and eight died (three from intercurrent complications and five with no liver regeneration).
Similar articles
-
Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis.
Silk DB, Trewby PN, Chase RA, Mellon PJ, Hanid MA, Davies M, Langley PG, Wheeler PG, Williams R. Silk DB, et al. Lancet. 1977 Jul 2;2(8027):1-3. doi: 10.1016/s0140-6736(77)90001-0. Lancet. 1977. PMID: 69100
-
Gardère JJ, Castaing Y, Gbikpi-Bénissan G. Gardère JJ, et al. Ann Fr Anesth Reanim. 1987;6(5):423-8. doi: 10.1016/s0750-7658(87)80368-4. Ann Fr Anesth Reanim. 1987. PMID: 3434887 French.
-
Opolon P, Lavallard MC, Crubille C, Gateau P, Nusinovici V, Granger A, Darnis F, Caroli J. Opolon P, et al. Nouv Presse Med. 1975 Dec 6;4(42):2987-91. Nouv Presse Med. 1975. PMID: 1221352 French.
-
Williams R. Williams R. Clin Gastroenterol. 1974 May;3(2):419-36. Clin Gastroenterol. 1974. PMID: 4608353 Review. No abstract available.
-
Use of sorbent columns and haemofiltration in fulminant hepatic failure.
Hughes RD, Williams R. Hughes RD, et al. Blood Purif. 1993;11(3):163-9. doi: 10.1159/000170113. Blood Purif. 1993. PMID: 8280438 Review.
Cited by
-
Knell AJ. Knell AJ. J R Coll Physicians Lond. 1980 Apr;14(2):117-23. J R Coll Physicians Lond. 1980. PMID: 6988585 Free PMC article. Review. No abstract available.
-
Development of a hybrid bioartificial liver.
Rozga J, Holzman MD, Ro MS, Griffin DW, Neuzil DF, Giorgio T, Moscioni AD, Demetriou AA. Rozga J, et al. Ann Surg. 1993 May;217(5):502-9; discussion 509-11. doi: 10.1097/00000658-199305010-00010. Ann Surg. 1993. PMID: 8489313 Free PMC article.
-
Hung TH, Tseng CW, Tseng KC, Hsieh YH, Tsai CC, Tsai CC. Hung TH, et al. Medicine (Baltimore). 2014 Sep;93(14):e79. doi: 10.1097/MD.0000000000000079. Medicine (Baltimore). 2014. PMID: 25255022 Free PMC article.
-
A bioartificial liver to treat severe acute liver failure.
Rozga J, Podesta L, LePage E, Morsiani E, Moscioni AD, Hoffman A, Sher L, Villamil F, Woolf G, McGrath M, et al. Rozga J, et al. Ann Surg. 1994 May;219(5):538-44; discussion 544-6. doi: 10.1097/00000658-199405000-00012. Ann Surg. 1994. PMID: 8185403 Free PMC article.
-
Liver support in acute liver failure.
Hughes RD. Hughes RD. Wien Klin Wochenschr. 2003 Sep 15;115(15-16):547-8. doi: 10.1007/BF03040446. Wien Klin Wochenschr. 2003. PMID: 14531165 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources